FIS Raises Full-year EPS Guidance - Quick Facts

FIS (FIS) announced, for 2018, the company now expects adjusted EPS of $5.14 to $5.34, an increase from prior outlook range of $5.10 to $5.30. Consolidated organic revenue is projected to increase in the range of 2.5 to 3.5 percent.

First-quarter adjusted net earnings attributable to common stockholders was $363 million or $1.09 per diluted share, compared to $0.82 per diluted share in the prior year quarter, an increase of 32.9 percent. For the first quarter, organic revenue increased 3.3 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Mallinckrodt plc announced Wednesday that the U.S. Food and Drug Administration or FDA has approved StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen - dsat) for the treatment of adult patients with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated. Worldwide 5G mobile subscriptions are estimated to exceed 580 million by the end of 2021, according to the Ericsson Mobility Report. With subscriptions increasing at a rate of about a million per day, 5G remains on track to become the fastest adopted mobile generation in history. The growth in subscriptions is being lead by China, North America and the Gulf Cooperation Council markets. Elanco Animal Health Inc. (ELAN) and veterinary biopharmaceutical company Kindred Biosciences, Inc. (KIN) announced Wednesday they have entered into a definitive agreement for Elanco to acquire Kindred for $9.25 per share, or approximately $440 million. The acquisition further accelerates Elanco's...
Follow RTT